tangeretin has been researched along with Obesity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Gu, Y; Jiang, Z; Wang, D; Zhou, Z | 1 |
| Chen, R; Jiang, S; Ke, Z; Li, H; Li, M; Li, Y; Tan, S | 1 |
| Cao, Y; Chen, T; Chen, Y; Feng, K; Ho, CT; Huang, Q; Lan, Y; Li, J; Zhu, X | 1 |
3 other study(ies) available for tangeretin and Obesity
| Article | Year |
|---|---|
Tangeretin prevents obesity by modulating systemic inflammation, fat browning, and gut microbiota in high-fat diet-induced obese C57BL/6 mice.
Topics: Adipocytes, White; Adipose Tissue, Brown; Animals; Bacteria; Diet, High-Fat; Dietary Supplements; Fatty Liver; Flavones; Gastrointestinal Microbiome; Glucose Intolerance; Inflammation; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Obesity; Thermogenesis | 2022 |
Tangeretin improves hepatic steatosis and oxidative stress through the Nrf2 pathway in high fat diet-induced nonalcoholic fatty liver disease mice.
Topics: Animals; Antioxidants; Diet, High-Fat; Disease Models, Animal; Flavones; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress | 2022 |
Hepatic Lipidomics Analysis Reveals the Antiobesity and Cholesterol-Lowering Effects of Tangeretin in High-Fat Diet-Fed Rats.
Topics: Animals; Anti-Obesity Agents; Cholesterol; Diet, High-Fat; Fatty Acids; Fatty Liver; Flavones; Humans; Lipidomics; Liver; Male; Obesity; Rats; Rats, Sprague-Dawley; Triglycerides | 2020 |